Kester, Kent E <br/><br/>
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research.  [electronic resource] 

 -  Vaccine  Apr 2008 
 - 2191-202 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2008.02.048  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Protozoan--blood<br/>Cells, Cultured<br/>Female<br/>Humans<br/>Immunization Schedule<br/>Interferon-gamma--biosynthesis<br/>Leukocytes, Mononuclear--immunology<br/>Malaria Vaccines--administration & dosage<br/>Malaria, Falciparum--prevention & control<br/>Male<br/>Middle Aged<br/>Parasitemia--prevention & control<br/>Protozoan Proteins--immunology